Pfizer announces deal worth up to $1.3 billion with Beam; Beam's stock is up 4.9%
Marketwatch -

Shares of Pfizer Inc. gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc. worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the four-year agreement, the companies will use Beam's vivo base editing technology to develop drugs that treat rare genetic diseases of the liver, muscle, and central nervous system. Pfizer will pay Beam $300 million upfront; including milestone payments, the deal could be worth...

Read this story at

Loading...

Related Articles